Refractory Adult T-Cell Leukemia/Lymphoma - CISMeF

" /> Refractory Adult T-Cell Leukemia/Lymphoma - CISMeF

CISMeF

chu

Refractory Adult T-Cell Leukemia/LymphomaNCIt concept

Preferred Label : Refractory Adult T-Cell Leukemia/Lymphoma;

NCIt synonyms : Adult T-Cell Lymphoma/Leukemia Refractory; Refractory Adult T-Cell Lymphoma/Leukemia; Refractory Adult T-Cell Lymphoma Leukemia;

NCIt definition : Adult T-cell leukemia/lymphoma that is resistant to treatment.;

Neoplastic status : Malignant;

Details

Origin ID

C8657;

UMLS CUI

C0854818;

Currated CISMeF NLP mapping
- Adult T-cell lymphoma/leukaemia refractory [MedDRA Preferred Term]
- Adult T-cell lymphoma/leukemia refractory [MedDRA LLT]
Disease excludes abnormal cell
- Lymphocyte Predominant Cell [NCIt concept]
- Neoplastic B-Lymphocyte [NCIt concept]
- Reed-Sternberg Cell [NCIt concept]
Disease excludes normal cell origin
- Myeloid Cell [NCIt concept]
- Plasma Cell [NCIt concept]
- Precursor Natural Killer Cell [NCIt concept]
- Precursor T-Lymphoblast [NCIt concept]
Disease may have findings
- Aggressive Clinical Course [NCIt concept]
Has associated anatomic sites
- Hematopoietic and Lymphatic System [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Adult T-cell lymphoma/leukaemia refractory [MedDRA Preferred Term]
- Adult T-cell lymphoma/leukemia refractory [MedDRA LLT]
concept_is_in_subset
- CTRP Disease Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
disease_has_abnormal_cell
- Abnormal Lymphocyte [NCIt concept]
- Malignant Cell [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Hematopoietic and Lymphoid Cell [NCIt concept]
- Neoplastic Lymphocyte [NCIt concept]
- Neoplastic T-Lymphocyte [NCIt concept]
- Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell [NCIt concept]
disease_has_associated_disease
- HTLV-1 Infection [NCIt concept]
- Infectious Disorder [NCIt concept]
- Viral Infection [NCIt concept]
disease_has_finding
- Adulthood Lesion [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
- Refractory Disease [NCIt concept]
disease_has_molecular_abnormality
- Clonal T-Cell Receptor Beta Chain Gene Rearrangement [NCIt concept]
- Clonal T-Cell Receptor Gamma Chain Gene Rearrangement [NCIt concept]
disease_has_normal_cell_origin
- CD4-Positive T-Lymphocyte [NCIt concept]
- Hematopoietic and Lymphoid Cell [NCIt concept]
- Lymphocyte [NCIt concept]
- Peripheral (Post-Thymic) T-Lymphocyte and Natural Killer Cell [NCIt concept]
- T-Lymphocyte and Natural Killer Cell [NCIt concept]
disease_has_normal_tissue_origin
- Hematopoietic and Lymphoid Tissue [NCIt concept]
- Lymphoid Tissue [NCIt concept]
disease_has_primary_anatomic_site
- Hematopoietic and Lymphatic System [NCIt concept]
- Lymphatic System [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
08/05/2025

© Rouen University Hospital. Any partial or total use of this material must mention the source.

" /> Refractory Adult T-Cell Leukemia/Lymphoma - CISMeF

CISMeF

chu

Refractory Adult T-Cell Leukemia/LymphomaNCIt concept

Preferred Label : Refractory Adult T-Cell Leukemia/Lymphoma;

NCIt synonyms : Adult T-Cell Lymphoma/Leukemia Refractory; Refractory Adult T-Cell Lymphoma/Leukemia; Refractory Adult T-Cell Lymphoma Leukemia;

NCIt definition : Adult T-cell leukemia/lymphoma that is resistant to treatment.;

Neoplastic status : Malignant;

Details

Origin ID

C8657;

UMLS CUI

C0854818;

Currated CISMeF NLP mapping
- Adult T-cell lymphoma/leukaemia refractory [MedDRA Preferred Term]
- Adult T-cell lymphoma/leukemia refractory [MedDRA LLT]
Disease excludes abnormal cell
- Lymphocyte Predominant Cell [NCIt concept]
- Neoplastic B-Lymphocyte [NCIt concept]
- Reed-Sternberg Cell [NCIt concept]
Disease excludes normal cell origin
- Myeloid Cell [NCIt concept]
- Plasma Cell [NCIt concept]
- Precursor Natural Killer Cell [NCIt concept]
- Precursor T-Lymphoblast [NCIt concept]
Disease may have findings
- Aggressive Clinical Course [NCIt concept]
Has associated anatomic sites
- Hematopoietic and Lymphatic System [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Adult T-cell lymphoma/leukaemia refractory [MedDRA Preferred Term]
- Adult T-cell lymphoma/leukemia refractory [MedDRA LLT]
concept_is_in_subset
- CTRP Disease Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
disease_has_abnormal_cell
- Abnormal Lymphocyte [NCIt concept]
- Malignant Cell [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Hematopoietic and Lymphoid Cell [NCIt concept]
- Neoplastic Lymphocyte [NCIt concept]
- Neoplastic T-Lymphocyte [NCIt concept]
- Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell [NCIt concept]
disease_has_associated_disease
- HTLV-1 Infection [NCIt concept]
- Infectious Disorder [NCIt concept]
- Viral Infection [NCIt concept]
disease_has_finding
- Adulthood Lesion [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
- Refractory Disease [NCIt concept]
disease_has_molecular_abnormality
- Clonal T-Cell Receptor Beta Chain Gene Rearrangement [NCIt concept]
- Clonal T-Cell Receptor Gamma Chain Gene Rearrangement [NCIt concept]
disease_has_normal_cell_origin
- CD4-Positive T-Lymphocyte [NCIt concept]
- Hematopoietic and Lymphoid Cell [NCIt concept]
- Lymphocyte [NCIt concept]
- Peripheral (Post-Thymic) T-Lymphocyte and Natural Killer Cell [NCIt concept]
- T-Lymphocyte and Natural Killer Cell [NCIt concept]
disease_has_normal_tissue_origin
- Hematopoietic and Lymphoid Tissue [NCIt concept]
- Lymphoid Tissue [NCIt concept]
disease_has_primary_anatomic_site
- Hematopoietic and Lymphatic System [NCIt concept]
- Lymphatic System [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
08/05/2025

© Rouen University Hospital. Any partial or total use of this material must mention the source.